The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Kirin Holdings Company, Limited
KNBWY · PNK · USD · Market cap $14.7B · 31,144 employees
Kirin Holdings Company, Limited engages in food and beverages, alcoholic beverages, pharmaceuticals, and health science businesses.
FAIL · Does not pass the screenPrice as of 16 Nov 2026Daily close, not a live quote
Screened 2026-11-16 · the tape above runs as of 10:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price20.09 USD at the 16 Nov 2026 close
- Fair value12.91. Our model only; no analyst estimate to cross-check.
- Our value readOvervalued vs our fair value, as of 16 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed16 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $11.80 to $19.67, base estimate $12.91 (screen dated 2026-11-16).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Kirin Holdings Company, Limited holds its Markup at $20.09. Consolidating, no directional conviction, held for 1 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $20.09 |
| Valuation | 11.92 trailing · 17.17 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.09 |
Five Screens, Shown in Full
Does not pass. Business activity: alcohol
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
| Debt load | 7,188.52% | Below 33% | Interest-bearing debt is 7,188.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 975.34% | Below 33% | Interest-bearing cash and securities are 975.3% of assets, above the one-third limit. | Fail |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.44% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Kirin Holdings Company, does not clear the screen at the business-activity stage. It operates in alcohol, so the financial ratios are not the deciding factor here.
Read as at 2026-11-16. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KNBWY's ethical verdict changes
Today KNBWY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our model only; no analyst estimate to cross-check.
Our analysis reads Overvalued vs our fair value, as of 16 Nov 2026: it trades above our $12.91 fair value estimate, moderate competitive moat, 9.20% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-16 screen. The gold marker is the market price at the same screen. The price runs 55.6% above the base estimate.
Where our models see it going: fair-value estimate $12.91, with a range of $11.80 to $19.67, dated to the 2026-11-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsKirin looks pricey and ethically stretched
Picture a Tokyo salaryman reaching for a Kirin lager after hours. The same group also sells soft drinks, dairy, wine and even runs a pharmaceuticals arm, yet none of that changes the simple numbers.
We pass. Shares sit 43 percent above our fair value, the forward multiple is 16.4 times, and the debt ratio already fails the ethical screen. Revenue growth of 5 percent and a 6 percent profit margin do not justify stretching the valuation further.
The moderate moat and 12 percent return on equity look steady on paper, yet high debt leaves the business exposed if consumer spending in Japan slows or interest costs rise. Analysis, not advice.
| Forward P/E | 17.2xpriced for continued growth |
| Trailing P/E | 11.9xreasonably valued |
| EPS, trailing | 1.57 |
| EPS, forward | 1.09 |
| Revenue growth | +9.2%steady growth |
| Profit margin | 7.8%thin but positive margins |
| Return on equity | 15.1%a solid return on shareholder capital |
| FCF yield | 1,538.29% |
| Dividend yield | 2.78% |
| Debt to equity | 0.50moderate, manageable leverage |
| Current ratio | 1.48adequate liquidity, worth monitoring |
| Beta | 0.09barely tracks the market's swings |
| 52-week range | 14.66 - 20.21 |
| Moat | MODERATE |
| Market cap | $14.7B |
| Employees | 31,144 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeKNBWY trades on PNK (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 14%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Kirin Holdings 9-mth profit rises 18% on strong alcohol sales Yahoo Finance · 6d ago
- Kirin (KNBWY) is an Incredible Growth Stock: 3 Reasons Why Yahoo Finance · 27d ago
- Are Investors Undervaluing Kirin (KNBWY) Right Now? Yahoo Finance · 27d ago
- Kirin Holdings Company (TSE:2503) Expands Kirin Ichiban In South Korea, Is It Still Undervalued? Yahoo Finance · 14 Oct 2026
- Kirin taps HiteJinro for South Korea beer production Yahoo Finance · 13 Oct 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $16.05 | +3.1% | · | $1,031 | +3.1% |
| 2 months | $16.70 | -0.9% | · | $991 | -0.9% |
| 3 months | $16.57 | -0.1% | · | $999 | -0.1% |
| 6 months | $15.14 | +9.3% | · | $1,093 | +9.3% |
| 1 year | $14.24 | +16.2% | $0.25 | $1,180 | +18.0% |
| 2 years | $13.62 | +21.5% | $0.49 | $1,251 | +25.1% |
| 3 years | $14.51 | +14.1% | $0.49 | $1,174 | +17.4% |
| 5 years | $20.40 | -18.9% | $0.49 | $835 | -16.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KNBWY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.